Journal article
In Reply
Abstract
This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID-19 pandemic, in response to the letter by Boutayeb et al.
Authors
Coomes EA; Al-Shamsi HO; Meyers BM; Alhazzani W; Alhuraiji A; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK
Journal
The Oncologist, Vol. 25, No. 8, pp. e1252–e1253
Publisher
Oxford University Press (OUP)
Publication Date
August 1, 2020
DOI
10.1634/theoncologist.2020-0329
ISSN
1083-7159